Previous studies have shown that transgenic CYP7A1 expression in mice has a profound impact on hepatic cholesterol metabolic pathways and completely prevents diet-induced hepatic steatosis and hypercholesterolemia45. This evidence concerns the gene CYP7A1 and fatty liver disease.